Market Research Logo

Japan Market Report for Uterine Fibroid Embolization Devices 2017 - MedCore

EXECUTIVE SUMMARY
1.1 JAPAN MARKET FOR GYNECOLOGICAL DEVICES OVERVIEW
1.2 COMPETITIVE ANALYSIS
1.3 MARKET TRENDS
1.4 MARKET DEVELOPMENTS
1.5 MARKETS INCLUDED
1.6 KEY REPORT UPDATES
1.7 VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.2 DISEASE PATHOLOGY AND DISORDERS
2.2.1 Introduction
2.2.2 General Diagnostics
2.2.3 Indications for Assisted Reproduction Technologies (ART)
2.2.3.1 ART cost: coverage policy and medical insurance in different countries
2.2.4 Abnormal Uterine Bleeding
2.2.5 Gynecologic Cancer and Tumors in Reproductive System
2.2.6 Indications for Female Sterilization
2.2.7 Urinary Incontinence
2.2.8 Indications for Pelvic Organ Prolapse Repair
2.2.9 Indications for CO2 Fractional Laser
PRODUCT ASSESSMENT
3.1 PRODUCT PORTFOLIOS
3.1.1 Uterine Fibroid Embolization
3.1.1.1 Introduction
3.1.1.2 Microspheres
3.1.1.3 Polyvinyl Alcohol Particles
3.1.1.4 Drug-eluting Particles
3.1.1.5 Product Matrix for Uterine Fibroid Embolization
3.2 REGULATORY ISSUES AND RECALLS
3.2.1 Uterine Fibroid Embolization
3.3 CLINICAL TRIALS
3.3.1 Uterine Fibroid Embolization
UTERINE FIBROID EMBOLIZATION DEVICE MARKET
4.1 INTRODUCTION
4.1.1 Microspheres
4.1.2 Polyvinyl Alcohol Particles
4.1.3 Drug-Eluting Particles
4.2 MARKET OVERVIEW
4.3 MARKET ANALYSIS AND FORECAST
4.3.1 Total Uterine Fibroid Embolization Device Market
4.3.2 Microsphere Market
4.3.3 PVA Particle Market
4.4 DRIVERS AND LIMITERS
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
APPENDIX: COMPANY PRESS RELEASES
List of Charts
Chart 1 1: Gynecological Device Market by Segment, Japan, 2013 – 2023
Chart 1 2: Gynecological Device Market by Segment, Japan, 2016 & 2023
Chart 4 1: Uterine Fibroid Embolization Device Market by Segment, Japan, 2013 – 2023
Chart 4 2: Uterine Fibroid Embolization Device Market Breakdown, Japan, 2016
Chart 4 3: Uterine Fibroid Embolization Device Market Breakdown, Japan, 2023
Chart 4 4: Total Uterine Fibroid Embolization Device Market, Japan, 2013 – 2023
Chart 4 5: Microsphere Market, Japan, 2013 – 2023
Chart 4 6: PVA Particle Market, Japan, 2013 – 2023
Chart 4 7: Leading Competitors, Uterine Fibroid Embolization Device Market, Japan, 2016
List of Figures
Figure 1 1: Gynecological Device Market by Segment, Japan, 2016 (1 of 2)
Figure 1 2: Gynecological Device Market by Segment, Japan, 2016 (2 of 2)
Figure 1 3: Companies Researched in this Report, Japan, 2016
Figure 1 4: Factors Impacting the Gynecological Device Market by Segment, Japan (1 of 2)
Figure 1 5: Factors Impacting the Gynecological Device Market by Segment, Japan (2 of 2)
Figure 1 6: Recent Events in the Gynecological Device Market, Japan, 2012 – 2016
Figure 1 7: Gynecological Device Markets Covered, Japan, 2016
Figure 1 8: Key Report Updates
Figure 1 9: Version History
Figure 2 1: Gynecological Disease Overview
Figure 2 2: ART Procedure Availability Overview
Figure 2 3: ART Procedure Availability Overview
Figure 3 1: Class 2 Device Recall: SpermMar Test
Figure 3 2: Uterine Fibroid Embolization: Safety and Efficacy of Embozene Microspheres for Uterine Fibroid Embolization
Figure 3 3: Uterine Fibroid Embolization: Embozene Microspheres for Uterine Fibroid Embolization (UFE)
Figure 4 1: Uterine Fibroid Embolization Device Market by Segment, Japan, 2013 – 2023 (JP¥M)
Figure 4 2: Uterine Fibroid Embolization Device Market by Segment, Japan, 2013 – 2023 (US$M)
Figure 4 3: Total Uterine Fibroid Embolization Device Market, Japan, 2013 – 2023
Figure 4 4: Microsphere Market, Japan, 2013 – 2023
Figure 4 5: PVA Particle Market, Japan, 2013 – 2023
Figure 4 6: Drivers and Limiters, Uterine Fibroid Embolization Device Market, Japan, 2016
Figure 4 7: Leading Competitors, Uterine Fibroid Embolization Device Market, Japan, 2016
Figure 6 1: Press Release Summary

Japan Market Report for Uterine Fibroid Embolization Devices 2017 - MedCore

Uterine fibroid embolization (UFE), also known as uterine artery embolization (UAE) is a radiology treatment for fibroids. Fibroids, also known as myomas, are masses of muscle tissue and fiber located on the wall of the uterus that can cause heavy bleeding and pain. Fibroids depend on the uterine arteries for nourishment, and they take significant blood supply from these vessels. UFE restricts blood flow to fibroids, causing them to shrink significantly. This procedure does not involve general anesthesia and is appropriate for women who want an alternative to a myomectomy, also known as fibroidectomy. It is a much less invasive way to treat fibroids than a hysterectomy, has a much shorter recovery time and leaves almost no scarring. The effects of UFE on fertility are being researched; some results suggest that fertility after UFE is comparable to fertility after myomectomy.


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;